Ortec International Inc.

29 articles about Ortec International Inc.

• U.S. Medtech Firm Ortec to Create 110 Jobs in Ireland

  9/13/2016

• Ortec International Inc. Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.

  1/10/2008

• Ortec International Inc. Announces Revised Date and Time for Presentation at New York Society of Security Analysts Conference

  12/11/2007

• Ortec International Inc. Selected to Present among Leading Life Science Companies at New York Society of Security Analysts Conference

  12/5/2007

• Ortec International Inc. Files PMA for OrCel(R) for VLU Indication

  10/23/2007

• Ortec International Inc. Announces New CEO

  7/11/2007

• Ortec International Inc. Initiates Premarket Approval (PMA) Application Filing Seeking Approval for OrCel(R) in Treating Venous Leg Ulcers

  2/26/2007

• Ortec International Inc. And Paul Capital Healthcare To Restructure Existing Financing Agreement

  11/30/2006

• FDA Issues Approvable Letter To Ortec International Inc. For Use Of Cryopreserved OrCel(R) In Epidermolysis Bullosa Patients' Hand Reconstructions And Donor Sites

  9/29/2006

• Ortec International Inc. Obtains Second U.S. Patent Allowance On Haptide Cell Attachment Technology

  9/20/2006

• Ortec International Inc. Announces Positive Results In Confirmatory Venous Leg Ulcer Trial

  9/12/2006

• Ortec International Inc.'s FDA Approved Cell Line Plays Pivotal Role In Creation Of First Embryonic Stem Cell Lines Fit For Human Clinical Trials

  8/3/2006

• Ortec International Inc. Announces Reverse Stock Split

  7/24/2006

• Cambrex Corporation And Ortec International Inc. Submit To FDA A Humanitarian Device Exemption (HDE) For OrCel(R) To Treat Epidermolysis Bullosa Patients

  7/18/2006

• Ortec International Inc. Issues Update On Its Three Technology Platforms For Regenerative Medicine And Stem Cells

  7/6/2006

• Ortec International Inc. Initiates Pre-Clinical Animal Model Study To Evaluate Fibrin Microbead Technology For Stem Cell Regeneration Of Non-Union Bone Defects

  6/22/2006

• Ortec International Inc. To Be Granted European Patent On Its Fibrin Microbead Enabling Technology For Stem Cell Isolation And Therapy

  6/20/2006

• Ortec International Inc. Obtains First U.S. Patent Allowance On Haptide(TM) Cell Attachment Technology

  6/1/2006

• Ortec International Inc. ExpectsTo File Humanitarian Device Exemption (HDE) Application With FDA Requesting Marketing Approval Of Cryopreserved OrCel(R) For Use In Epidermolysis Bullosa Patients

  5/30/2006

• Ortec International Inc. CEO Details Corporate Vision And Mission In Letter To Shareholders

  5/23/2006